When the first set of prices under the Medicare Drug Price Negotiation Program went into effect, they intersected with the 340B Drug Pricing Program and created the potential for billions of dollars ...
Hospitals already losing money face billions in 340B cuts, site-neutral imaging rates, and Medicaid rollbacks in CMS' 2027 outpatient rule.
The Health Resources and Services Administration (HRSA) announced that it is moving forward with a revised 340B rebate pilot that would allow qualifying drug manufacturers to provide post-purchase ...
Opinion
3dOpinion
Guest Commentary: Flawed drug-pricing plan bought a criminal a Bentley with your tax dollars
The 340B Drug Pricing Program, meant for low-income patients to get cheaper medications, is being exploited. Its loopholes must be closed.
A proposed rule issued last month by the Centers for Medicare & Medicaid Services (CMS) would affect Medicare payment rates for both ...
It’s deadline day for public input into a major policy shift in Medicaid, the federal-state health care coverage program that cares for nearly 67 million low-income and people with disabilities.
Healthcare needs more leaders willing to call their babies ugly. This kind of self-indictment will be necessary for the ...
On August 3, 2026, the Health Resources and Services Administration (HRSA) published a revised 340B Rebate Pilot Program (the “Pilot Program”) in ...
Kaine pitches reforms for drug pricing program supporting underserved patients, safety net providers
Known as 340B, the program has helped Virginia hospitals and clinics and others nationwide care for underserved patients by ...
The Health Resources & Services Administration has unveiled its formal plans for a revised version of its contentious 340B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results